March 31, 2020 · eight:00 AM
From the U.S. Meals and Drug Administration:
ISSUE: FDA has requested that the producer of Belviq, Belviq XR (lorcaserin) voluntarily withdraw the weight-loss drug from the U.S. market as a result of a security scientific trial reveals an elevated prevalence of most cancers. The drug producer, Eisai Inc,. has submitted a request to voluntarily withdraw the drug. When FDA accredited lorcaserin in 2012, we required the drug producer to conduct a scientific trial to guage the danger of cardiovascular issues. A spread of most cancers sorts was reported, with a number of various kinds of cancers occurring extra continuously within the lorcaserin group, together with pancreatic, colorectal, and lung.
BACKGROUND: In January 2020, FDA introduced we had been reviewing scientific trial knowledge and alerted the general public a few potential danger of most cancers related to lorcaserin primarily based on preliminary evaluation of the information.
RECOMMENDATION: PatientsPatients ought to cease taking lorcaserin and discuss to your well being professionals about different weight-loss medicines and weight administration packages.
Supply: Belviq, Belviq XR (lorcaserin) by Eisai: Drug Security Communication – FDA Requests Withdrawal of Weight-Loss Drug | FDA
I by no means ran throughout a affected person taking it, nor did I ever prescribe it. There are higher methods to drop a few pounds.
Steve Parker, M.D.
Click on the pic to buy at Amazon.com. E-book variations additionally obtainable at Smashwords. com